CDK4 and cancer: A possible explanation for its oncomiR function in this setting might derive from non-cancer models such as ARDS, where miR-877-5p suppressed CDKN1B which encodes p27Kip1, whose downregulation is claimed as one of the possible mechanisms of resistance to CDK4/6i [26].